Find out the winner of the 23rd edition of the Syva Award!
Dr Roberto Sánchez Sánchez, from Madrid Complutense University, with his research work “Toxoplasmosis and neosporosis in domestic ruminants: normalization of animal models and evaluation of new drugs” won the 23rd Syva Award for best Doctoral Thesis in Animal Health of €15,000. Congratulations!
The winning thesis was presented under the supervision of Drs Luis Miguel Ortega Mora, Ignacio Ferre Pérez and Michela Tatiana Re.
Dr Roberto Sánchez Sánchez is a vet who graduated from León University (2012) and was awarded a Doctorate “cum laude” from Madrid Complutense University, with a minor International Doctorate (2018).
He is currently a postdoctorate researcher with the UCM’s SALUVET group and has a contract with the Technological Platform for Research into Animal Health (PLATESA) for the Community of Madrid.
The Selection Board was chaired by Dr César B. Gutiérrez Martín (ULE), and comprised of Drs Ricardo de la Fuente López (UCM), Javier Lucientes Curdi (Unizar) and Rosario Bullido Gómez de las Heras (AEMPS). It also included Dr Maria Luisa de Arriba Martín, from Laboratorios Syva.
The research topic tackled Toxoplasma gondii and Neospora caninum, apicomplexan parasites responsible for reproductive failure in ovine-caprine livestock and bovine livestock, respectively. Moreover, T. gondii is a zoonotic agent with broad global distribution. Animal models are an essential tool to study the pathogeny of disease and to develop drugs and vaccines.
Currently, there are no effective drugs to treat these diseases in ruminants. The calcium dependent protein, kinase 1 (CDPK1), has recently been reported, against which a group of drugs known as “Bumped Kinase Inhibitors” (BKIs) have been developed with promising results.
The aim of the thesis was to normalize expectant ovine models with T. gondii and N. caninum infection and, using these, evaluate the safety and efficacy of BKIs. The thesis results comprise an essential proof of concept to reveal the usefulness of these compounds in monitoring both diseases in domestic ruminants.
You may also be interested in
2 March, 2023
SYVA announces its partnership with the biotech SMIVET for the development of SDA [SDA]
León - Technology Park – Spain, March 2, 2023 - SYVA and SMIVET signed a collaboration agreement that allow both companies to develop therapeutic solutions based on Single Domain Antibodies (SDA). With this agreement, Syva expresses its willingness to invest in new biotechnologies with the objective to continue to grow and improve its attractiveness by researching, developing, and producing...
15 February, 2023
The earthquake in Turkey affected Syva’s collaborators
From Syva we are wholeheartedly with our colleagues and The Turkish population. We want to express our support in this difficult time. We continue daily to analyse the situation and we evaluate with our contact in Turkey, how we can best support them.
23 December, 2022
Merry Christmas and a Happy New Year 2023!
Time flies and here we are already on the eve of Christmas and New Year’s celebrations for most people around the world. It’s time for us to take a little rest with our families and to wish you wonderful festivities with your family, friends, and why not at home watching a good movie. Each one according to its...
Media tool kit
We provide users, particularly journalists and the press, with a series of graphic documents, photographs and videos. We offer the free use of these documents under certain conditions
Journalist and Press Contact
Are you a journalist, part of the press or the media? Do you want to get information on our activities, validate your sources in a professional manner, obtain validated photographic material or request an interview?
Next Events
